首页> 美国卫生研究院文献>other >Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes
【2h】

Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes

机译:使用SPECT / CT和闪烁探头对骨组织工程复合材料中BMP-2保留和骨形成进行无创监测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-invasive imaging can provide essential information for the optimization of new drug delivery-based bone regeneration strategies to repair damaged or impaired bone tissue. This study investigates the applicability of nuclear medicine and radiological techniques to monitor growth factor retention profiles and subsequent effects on bone formation. Recombinant human bone morphogenetic protein-2 (BMP-2, 6.5 μg/scaffold) was incorporated into a sustained release vehicle consisting of poly(lactic-co-glycolic acid) microspheres embedded in a poly(propylene fumarate) scaffold surrounded by a gelatin hydrogel and implanted subcutaneously and in 5-mm segmental femoral defects in 9 rats for a period of 56 days. To determine the pharmacokinetic profile, BMP-2 was radiolabeled with 125I and the local retention of 125I-BMP-2 was measured by single photon emission computed tomography (SPECT), scintillation probes and ex vivo scintillation analysis. Bone formation was monitored by micro-computed tomography (μCT). The scaffolds released BMP-2 in a sustained fashion over the 56-day implantation period. A good correlation between the SPECT and scintillation probe measurements was found and there were no significant differences between the non-invasive and ex-vivo counting method after 8 weeks of follow up. SPECT analysis of the total body and thyroid counts showed a limited accumulation of 125I within the body. Ectopic bone formation was induced in the scaffolds and the femur defects healed completely. In vivo μCT imaging detected the first signs of bone formation at days 14 and 28 for the orthotopic and ectopic implants, respectively, and provided a detailed profile of the bone formation rate. Overall, this study clearly demonstrates the benefit of applying non-invasive techniques in drug delivery-based bone regeneration strategies by providing detailed and reliable profiles of the growth factor retention and bone formation at different implantation sites in a limited number of animals.
机译:非侵入性成像可以为优化基于新药物递送的骨再生策略提供必要的信息,以修复受损或受损的骨组织。这项研究调查了核医学和放射学技术对监测生长因子保留特征及其对骨形成的影响的适用性。将重组人骨形态发生蛋白2(BMP-2,6.5μg/支架)掺入由聚(乳酸-乙醇酸)微球包裹的缓释载体中,该微球包埋在被明胶水凝胶包围的聚(富马酸丙烯)支架中并在9天的大鼠中皮下植入5毫米节段性股骨缺损,历时56天。为了确定药代动力学特征,对BMP-2进行了 125 I放射性标记,并通过单光子发射计算机断层扫描(SPECT)测量了 125 I-BMP-2的局部保留。 ,闪烁探针和离体闪烁分析。通过微计算机断层扫描(μCT)监测骨形成。支架在植入56天后持续释放BMP-2。随访8周后,发现SPECT与闪烁探针测量值之间具有良好的相关性,无创计数和离体计数方法之间无显着差异。对全身和甲状腺计数的SPECT分析表明, 125 I在体内的积累有限。在支架中诱发异位骨形成,股骨缺损完全愈合。体内μCT成像分别在第14天和第28天检测到了原位和异位植入物的骨形成的初步迹象,并提供了骨形成速率的详细资料。总体而言,这项研究通过在数量有限的动物中的不同植入部位提供生长因子保留和骨形成的详细而可靠的资料,清楚地证明了在基于药物输送的骨再生策略中应用非侵入性技术的好处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号